LG Chem (051910) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
23 Jun, 2026Executive summary
Q3 2025 saw consolidated sales of RMB 11.196 trillion (₩11,196 bn), operating profit of RMB 680 billion (₩680 bn), and net income of RMB 447 billion (₩447 bn), marking a return to profitability with an improved operating margin of 6.1% from the previous quarter.
Profitability was driven by cost reductions, lower raw material prices, and a one-time upfront payment in Life Sciences.
The business environment remains challenging due to weak global demand, easing of U.S. environmental regulations, and geopolitical uncertainties.
Financial highlights
Assets at Q3-end were RMB 98.5 trillion (₩98.5 trillion), liabilities RMB 52.2 trillion, and capital RMB 46.2 trillion.
Operating margin improved to 6.1% from the previous quarter; gross margin rose to 21.3% in Q3 2025.
Cash and equivalents at quarter-end were ₩8,593 bn.
EBITDA for Q3 2025 was KRW 1,992 bn, up from KRW 1,715 bn in Q2 2025.
R&D expenses totaled ₩1.77 trillion, representing 5.1% of sales.
Outlook and guidance
Continued weak global demand expected in Q4 and into 2026, with profitability likely to drop in Q4 due to scheduled plant turnaround.
2026 outlook remains cautious due to ongoing capacity additions in Asia and persistent oversupply, but focus will be on high-value-added products and cost savings.
Advanced Materials expects demand decline to persist due to policy changes and conservative inventory management.
New cathode shipments for Toyota to begin next year, with growth momentum expected by 2026.
Latest events from LG Chem
- Q2 sales rose, but net income and guidance fell amid weak demand and higher costs.051910
Q2 202423 Jun 2026 - Q3 profit rose on Energy Solution gains, but outlook remains cautious amid market headwinds.051910
Q3 202423 Jun 2026 - Q1 2025 saw improved profitability and strong battery sales amid ongoing market volatility.051910
Q1 202523 Jun 2026 - Operating profit improved, but net income was negative amid persistent market headwinds.051910
Q2 202523 Jun 2026 - Q1 2026 saw strong sales but a net loss, with batteries and petrochemicals as key drivers.051910
Q1 202622 Jun 2026 - Lower 2024 profits and weak demand drive restructuring, cost control, and cautious investment.051910
Q4 202428 May 2026 - Accelerating growth in sustainability, battery materials, and new drugs to drive future value.051910
Corporate presentation20 May 2026 - Four growth drivers are set to triple their revenue share by 2030 through strategic restructuring.051910
Corporate presentation20 May 2026 - Driving global sustainability and innovation with advanced materials and life sciences.051910
Corporate presentation20 May 2026